Navigation Links
Alticor's 2007 Global Sales Top $7 Billion
Date:2/6/2008

orld, joins its sister hotel, the newly renovated Amway Grand Plaza Hotel, in downtown Grand Rapids near the DeVos Place convention center and Van Andel Arena.

Aside from hotels, ACE is a critical component in Alticor's strategy to generate fresh thinking and ideas within the company. Only into its second year of operations, ACE acts as a holding company for Alticor's non-direct selling companies.

"With the help of Corporate Enterprises, we are building our capabilities in health and beauty, while also giving us immediate access to new technologies and products," said Jim Weaver, ACE's vice president. "It brings us closer to the marketplace, which will provide a wellspring of benefits to Alticor and Amway."

Alticor's 2006 acquisition of Gurwitch Products, a luxury cosmetics and skin-care company, is already paying dividends. Gurwitch, which develops and markets cosmetics under the brand name Laura Mercier(R), which are sold by The Neiman Marcus Group and other high-end retailers, gives Alticor access to insightful marketing, research and development talent in the premium beauty industry.

Fulton Innovation unveiled its eCoupled(TM) Intelligent Wireless Power Technology at the 2007 Consumer Electronics Show in Las Vegas, demonstrating how electronic devices such as cell phones can be recharged wirelessly. A year later, at the 2008 CES, eCoupled demoed wireless power conversion for an even wider array of electronic devices, ranging from a wirelessly powered laptop and cell phone to an Apple iPod and a George Foreman grill. eCoupled was granted 20 new patents in 2007, bringing its total to 58 U.S. and 143 international patents granted, published or pending.

In 2007, Alticor further increased its majority interest in publicly listed Interleukin Genetics, whose expertise in functional genomics assists ACE and Alticor in developing personalized, over-the-counter nutritional and skin-care products. Alticor also markets consumer genetic tes
'/>"/>

SOURCE Alticor Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. HMS Holdings Corp. to Present at 2008 UBS Global Healthcare Services Conference
2. West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference
3. World Cancer Campaign Builds Momentum Globally with International Initiative to Protect Children From Secondhand Smoke
4. Global Consensus on Mercury: Scientists Defend Science Journalists
5. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
6. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
7. Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11
8. Triple-S Management Corporation to Present at UBS Global Healthcare Conference
9. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
10. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...clinical trial results could lead to availability ...reatment for deep lines and wrinkles by 2009. , ...y 24, 2008 -- Gel-Del Technologies , a St. Paul, ...d that it has concluded clinical trials of Cosmeta...ials say holds potential to be a more effective al...
(Date:7/23/2008)... the Financing Needs of European and A... YORK, July 24 /PRNewswire/ -- Paul Capital Partne...en promoted to Partner. Based in Paul,Capital,s Lo...ng,evaluating and negotiating European and Asian ...apital Healthcare funds., "Since he joined Paul C...
(Date:7/23/2008)...out-of-state intended parents, SAN RAMON, Calif.,...reme Court decision to allow gay couples to marry ...ence Center of the Bay Area (RSC), one of,the stat...nd lesbians for,infertility treatment., "Californ...C,s,long-held views that procreation is a natural ...
(Date:7/23/2008)...Call/ -- The Hanover Insurance Group,a leading su...announced it,is prepared to respond to claims resu...ugh southern Texas today., (Logo: http://www.new... are deeply concerned about individuals and busine...ent of The Hanover,s Central Region. "Our,staff is...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...der women suffering from chronic cytomegalovirus//...in life) were found to have more than triple the r... infection. This was reported in the Journal of th...time an association between CMV and frailty syndro...
...echnique to increase blood flow to the heart// tha...o increase 5 years of patients’ life than the coro...dical Center, US, have found that patients who had...eries have more life span when they undergo arteri...
...s with the help of seroquel is effective//, says a...bling mental illness. Some of the symptoms suffere...d, feelings of being persecuted, becoming withdraw...a can be treated symptomatically, but only one in ...
...od lower risk// of stroke.This link between childh... in a very interesting study published in the jour...n adults is not just due to exposure to risk facto...lated event over an entire lifetime. Previous stud...
Other Medicine News:Health News:Association between childhood diet and stroke 2
(Date:7/23/2008)...uly 23 /- Sound Pharmaceuticals (SPI)... with the FDA for the clinical,testing of a propri...,chemotherapy induced hearing loss or ototoxicity....ll be tested in advanced stage lung cancer,and hea...d chemotherapy.,This marks the second development ...
(Date:7/23/2008)...SCO, July 23 /- InCode BioPharmaceuti...oday announced preclinical test,results demonstrat... for,the treatment of the rare chronic blood disor... complete results will be presented at the XXII,In...and, September 28,2008., The only treatment curr...
(Date:7/22/2008)...fficacy results from a multi-center 293-patient Eu...onto Stock Exchange Symbol: CYT, MONTREAL, July 2...s,Inc., the global leader in cryotherapy products ... results previously presented from three,European ...ctic Front(R),were published earlier today in the...
(Date:7/22/2008)...strates Feasibility and Efficacy of Treating Patie...ncer, SAN FRANCISCO, and YONGIN-SI, South Korea, ...sco, CA and Ottawa, Ontario), and its South,Korean...ovel findings from,a Phase I clinical trial of its...hat the product was well-tolerated and resulted in...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 1APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 2Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 1Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 2New study finds resistant organisms at core of soft contact lens corneal infections 10235 1New study finds resistant organisms at core of soft contact lens corneal infections 10235 2Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast 2766 1
...ne, the U.S.-based subsidiary of,Pharmexa A/S, pre...gram today at the Influenza Conference entitled, "...Toronto, Ontario, Canada. The,data show that a "un...immune responses can protect transgenic mice again..., HORSOLM, Denmark, June 21, 2007-Pharmexa-Epimmun...
... June 21, 2007 - “In anaplastic,astrocytoma,...erior,to temozolomide,” Prof. Albert Wong, M...nted on the international Phase,IIb study with the...by Antisense Pharma. Prof. Wong discussed the resu...on central nervous system tumors,at the 43rd Annua...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
...es, the Advantage Smart Table goes up to 6 inches ...h to accommodate all open procedures. Controlled w...sitions for various surgeons and procedures. One b...to level. The simple unidirectional set-up of the ...
Inquire
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein.
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability.
Medicine Products: